Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Greer Laboratories is a U.S. allergy immunotherapy company operating as part of Stallergenes Greer, a global biopharmaceutical group focused on diagnosing and treating allergies. The business develops, manufactures, and commercializes allergenic extracts, skin testing products, and customized immunotherapy formulations for both human and veterinary use. Its portfolio is centered on allergy testing and desensitization products rather than a broad traditional drug-development pipeline. Greer has longstanding manufacturing operations in North Carolina and serves clinicians with products for subcutaneous immunotherapy and related allergy care workflows. Within the broader group structure, Greer functions as the U.S. operating subsidiary of Stallergenes Greer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Greer Biologics.